drugset / Trial / NCT06344936

Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects

NCT06344936

Phase 1 Unknown 28 enrolled Shandong Suncadia Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The study was designed to evaluate the pharmacokinetic effects of itraconazole and rifampicin on HRS-1780 after oral administration of HRS-1780 tablets in healthy subjects

Timeline

Start
2024-04
Primary completion
2024-07
Completion
2024-07

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-1780 Small molecule 10 mg Oral
Subject Itraconazole Small molecule 200 mg
Subject Rifampin Small molecule 600 mg